Comment by Irene

Yes, there could be many different scenarios; when vaccine supply is limited, vaccinate those at risk of death. BioNTech claims their vaccine efficacy is consistent across age groups, but we won't know for sure until large clinical trials are completed. Also, older people are less willing to be vaccinated earlier. More variables to include in the model...